Please try another search
OLIPASS Corporation, together with its subsidiaries, focuses on developing therapeutic products in South Korea. The company develops its products using its novel PNA based technologies. Its products pipeline includes, SCN9A for pain; PCSK9 for hyper cholesterolemia; VEGF; HIF-1a; Dystrophin; and PTP1B products. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin, south Korea. OLIPASS Corporation, together with its subsidiaries, focuses on developing therapeutic products in South Korea. The company develops its products using its novel PNA based technologies. Its products pipeline includes, SCN9A for pain; PCSK9 for hyper cholesterolemia; VEGF; HIF-1a; Dystrophin; and PTP1B products. OLIPASS Corporation was founded in 2006 and is headquartered in Yongin-si, South Korea.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review